- Home
- KURA vs SSYS Comparison
KURA vs SSYS Comparison
Compare KURA & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- SSYS
- Stock Information
- Founded
- KURA 2014
- SSYS 1989
- Country
- KURA United States
- SSYS United States
- Employees
- KURA N/A
- SSYS N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- SSYS Computer peripheral equipment
- Sector
- KURA Health Care
- SSYS Technology
- Exchange
- KURA Nasdaq
- SSYS Nasdaq
- Market Cap
- KURA 793.2M
- SSYS 673.9M
- IPO Year
- KURA N/A
- SSYS 1994
- Fundamental
- Price
- KURA $9.48
- SSYS $10.04
- Analyst Decision
- KURA Strong Buy
- SSYS Strong Buy
- Analyst Count
- KURA 10
- SSYS 4
- Target Price
- KURA $30.13
- SSYS $11.50
- AVG Volume (30 Days)
- KURA 2.9M
- SSYS 683.6K
- Earning Date
- KURA 11-07-2024
- SSYS 11-13-2024
- Dividend Yield
- KURA N/A
- SSYS N/A
- EPS Growth
- KURA N/A
- SSYS N/A
- EPS
- KURA N/A
- SSYS N/A
- Revenue
- KURA N/A
- SSYS $578,436,000.00
- Revenue This Year
- KURA N/A
- SSYS N/A
- Revenue Next Year
- KURA $106.66
- SSYS $3.22
- P/E Ratio
- KURA N/A
- SSYS N/A
- Revenue Growth
- KURA N/A
- SSYS N/A
- 52 Week Low
- KURA $9.40
- SSYS $6.05
- 52 Week High
- KURA $24.17
- SSYS $14.93
- Technical
- Relative Strength Index (RSI)
- KURA 24.01
- SSYS 59.81
- Support Level
- KURA $9.40
- SSYS $9.64
- Resistance Level
- KURA $10.02
- SSYS $10.87
- Average True Range (ATR)
- KURA 0.46
- SSYS 0.55
- MACD
- KURA 0.10
- SSYS -0.02
- Stochastic Oscillator
- KURA 8.09
- SSYS 69.95
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.